IPP Bureau
Dr. Mahesh N. Padamwar joins MSN Laboratories as Senior General Manager
By IPP Bureau - June 11, 2026
Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions
Glenmark launches Winlevi across key European markets
By IPP Bureau - June 11, 2026
First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe
ASMS explores strategic research collaboration with Mediciti Institute
By IPP Bureau - June 11, 2026
Partnership discussions focus on clinical validation, real-world evidence generation and adoption of indigenous diagnostic technologies across healthcare settings
Cloudnine Hospitals launches one-year fellowship for obstetricians and gynaecologists
By IPP Bureau - June 11, 2026
Programme aims to strengthen fertility care expertise through advanced clinical training, mentorship and hands-on experience in reproductive medicine
Bayer’s asundexian moves into EU regulatory review as stroke prevention race intensifies
By IPP Bureau - June 11, 2026
The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy
Shaquille O’Neal partners with Lilly in National Awareness push for Zepbound
By IPP Bureau - June 11, 2026
The campaign aims to raise awareness of a condition that affects an estimated 24 million adults in the US, many of whom remain undiagnosed
Thyrocare expands in UP with new Prayagraj lab to boost diagnostic access
By IPP Bureau - June 11, 2026
The Prayagraj lab is designed to handle both routine and specialised testing
DFE Pharma wins third straight EcoVadis Gold Medal
By IPP Bureau - June 11, 2026
The award places the company in the top 5% globally
Dr. Alka Rao becomes first woman director of CSIR-IMTECH
By IPP Bureau - June 11, 2026
Accomplished molecular microbiologist and protein engineer takes charge of CSIR-IMTECH after serving in key scientific and regulatory leadership roles at FSSAI
Malabar Group partners with Institute of Palliative Medicine to launch Malabar Care Connect
By IPP Bureau - June 11, 2026
Digital platform aims to expand access to palliative care through teleconsultations, training, community engagement and global knowledge-sharing
Sygnature Discovery partners with DaltonTx to enhance AI-driven drug discovery capabilities
By IPP Bureau - June 11, 2026
Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery
Alembic Pharma receives USFDA tentative approval for generic Larotrectinib capsules
By IPP Bureau - June 11, 2026
Company may qualify for 180-day generic exclusivity as sole first applicant for Bayer’s Vitrakvi capsules in the U.S.
AstraZeneca gets CDSCO nod for Trastuzumab Deruxtecan plus Pertuzumab
By IPP Bureau - June 11, 2026
Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer
GSK bets big on oncology with $10.6 billion Nuvalent acquisition
By IPP Bureau - June 10, 2026
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
Ten years on, PMSMA continues to shape safer motherhood in India
By IPP Bureau - June 10, 2026
7.5 crore antenatal check-ups and 1.2 crore high-risk pregnancies identified under flagship programme as maternal and neonatal mortality declines
